Insulin costs soar in Iran as insurance fails to keep up

Iran International · July 1, 2026 Human Rights

Rising drug prices and lagging insurance coverage are pushing diabetes medication further out of reach in Iran, documents obtained by Iran International show, with one patient’s NovoMix FlexPen insulin payment rising more than 24-fold in less than two months.